Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

New antithrombotic serine protease inhibitor patented by former Pharmacia

Sep. 17, 2003

First antithrombotic agent that acts by inhibiting Bruton's tyrosine kinase (BTK)

Sep. 16, 2003

Merck presents synthesis, SAR for a series of imidazole acetic acid TAFI inhibitors

Sep. 15, 2003

AxyS presents novel factor VIIa/factor Xa inhibitors

Sep. 12, 2003

New TAFI inhibitors for thrombotic disorders under evaluation at Pfizer

Sep. 3, 2003

Melagatran combined with ximelagatran may be effective in preventing postoperative thromboembolism

Sep. 2, 2003

PHA-927F reported to be a potent and selective inhibitor of tissue factor/factor VIIa

Aug. 27, 2003

Transkaryotic Therapies retakes Factor VIII gene therapy rights from Wyeth

Aug. 18, 2003

New factor XIIIa inhibitors prepared and tested at Curacyte

Aug. 7, 2003

Submission of European MAA, U.S. sNDA for Angiomax

Aug. 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...